Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 56:e9-e10, 2007
DOI: 10.2337/db07-0479
© 2007 by the American Diabetes Association
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hattori, Y.
Right arrow Articles by Nakano, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hattori, Y.
Right arrow Articles by Nakano, Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Letters to the Editor

Response to Comment on: Goldstein et al. (2007) Globular Adiponectin Activates Nuclear Factor-{kappa}B and Activating Protein-1 and Enhances Angiotensin II–Induced Proliferation in Cardiac Fibroblasts: Diabetes 56:804–808

Yoshiyuki Hattori1, and Yasuko Nakano2

1 Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi, Japan
2 Department of Medicinal Information, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan

Address correspondence to Yoshiyuki Hattori, MD, Department of Endocrinology and Metabolism, Dokkyo Medical University School of Medicine, Mibu, Tochigi 321-0293, Japan. E-mail: yhattori{at}dokkyomed.ac.jp

Goldstein et al. (1) expressed concern that our findings of nuclear factor-{kappa}B (NF-{kappa}B) activation by the globular domain adiponectin appear to contradict a substantial body of published and ongoing work. We showed that globular adiponectin activates redox-sensitive transcription factors in two different cell types: vascular endothelial cells and cardiac fibroblasts (2,3). These findings do not always contrast with a substantial body of published work. Indeed, a very recent report suggests that adiponectin exerts proinflammatory activities in colon by inducing production of proinflammatory cytokines and inhibiting bioactivity of protective growth factors (4). As initially reported by Ouchi et al. (5), adiponectin suppresses inflammatory endothelial responses, including reversing the activation of NF-{kappa}B and reducing adhesion molecule expression. In their study, however, endothelial cells were preincubated for 18 h with adiponectin and then exposed to tumor necrosis factor (TNF)-{alpha} (5). This long preincubation may cause hyporesposiveness or desensitization to TNF-{alpha} through preactivation of NF-{kappa}B. Indeed, our data show that TNF-{alpha}–induced NF-{kappa}B–mediated gene transcription was suppressed by globular adiponectin pretreatment in a dose-dependent manner when cells were pretreated with various concentrations of globular adiponectin for 16 h and followed by stimulation with TNF{alpha}, while coactivation of adiponectin with TNF{alpha} further increased the TNF-{alpha}–induced NF-{kappa}B–mediated gene transcription (2,3). Thus, timing of addition of adiponectin appears to be an important factor, at least in experiments with cultured cells.

We are now investigating the effects of high–molecular weight (HMW) adiponectin on endothelial cells compared with globular adiponectin, as experimental and clinical data suggest that the oligomeric complex distribution of adiponectin is critical for the antidiabetic and antiatherogenic activity of this hormone (6). We purified HMW adiponectin, which mainly consists of 18 molecules, from human plasma (7). Microarray analysis of cDNA from the RNA prepared from vascular endothelial cells untreated or treated with HMW adiponectin for 8 h revealed that HMW adiponectin modestly increased the expression of intracellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1. HMW adiponectin was found to modestly activate NF-{kappa}B and needs a shorter preincubation time to be inhibitory against TNF-{alpha}–induced NF-{kappa}B activation when compared with globular adiponectin. On the other hand, HMW adiponectin activated AMPK, which causes increased phosphorylation of endothelial nitric oxide synathase at Ser1177, and increased nitric oxide production in a manner similar to that of globular adiponectin (8). HMW and globular adiponectin may activate similar cell-signaling pathways, but to different degrees, through the same receptors (9). However, the manner of interaction with receptors and postbinding events probably differ. We are currently investigating this issue.

Waki et al. (10) demonstrated that adiponectin can be cleaved by leukocyte elastase secreted from activated monocytes and/or neutrophils, and this cleavage could be a possible mechanism for the generation of the globular fragment of adiponectin in plasma. However, it is unknown whether adiponectin cleavage in inflammatory sites results in sufficient globular adiponectin concentration to activate NF-{kappa}B. Under normal conditions, higher concentrations of HWM adiponectin flow in the vessels. This indicates that the basic function of adiponectin is to protect against inflammatory stimuli, whereas adiponectin cleavage at inflammatory sites might facilitate the atherogenic process and cardiac hypertrophy.

Received for publication April 5, 2007 and accepted in revised form April 5, 2007


    REFERENCES
 TOP
 REFERENCES
 

  1. Goldstein BJ, Scalia R, Ma XL, Mahadev K, Wu X, Ouedraogo R: Comment on: Goldstein et al. (2007) Globular adiponectin activates nuclear factor-{kappa}B and activating protein-1 and enhances angiotensin II–induced proliferation in cardiac fibroblasts. Diabetes 56:e7–e8, 2007. DOI: 10.2337/db07-0328[Free Full Text]
  2. Hattori Y, Hattori S, Kasai K: Globular adiponectin activates nuclear factor-{kappa}B in vascular endothelial cells, which in turn induces expression of proinflammatory and adhesion molecule genes. Diabetes Care 29:139–141, 2006[Free Full Text]
  3. Hattori Y, Hattori S, Akimoto K, Nishikimi T, Suzuki K, Matsuoka H, Kasai K: Globular adiponectin activates nuclear factor-{kappa}B and activating protein-1 and enhances angiotensin II–induced proliferation in cardiac fibroblasts. Diabetes 56:804–808, 2007[Abstract/Free Full Text]
  4. Fayad R, Pini M, Sennello JA, Cabay RJ, Chan L, Xu A, Fantuzzi G: Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 132:601–614, 2007[Medline]
  5. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102:1296–1301, 2000[Abstract/Free Full Text]
  6. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y: Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94:e27–e31, 2004[Abstract/Free Full Text]
  7. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M: Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 120:803–812, 1996[Abstract/Free Full Text]
  8. Hattori Y, Suzuki M, Hattori S, Kasai K: Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 46:1543–1549, 2003[Medline]
  9. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769, 2003[Medline]
  10. Waki H, Yamauchi T, Kamon J, Kita S, Ito Y, Hada Y, Uchida S, Tsuchida A, Takekawa S, Kadowaki T: Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146:790–796, 2005[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hattori, Y.
Right arrow Articles by Nakano, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hattori, Y.
Right arrow Articles by Nakano, Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum